Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

Pituitary- Netherlands

doi 10.1007/s11102-019-00984-6

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Thioguanine in Inflammatory Bowel Disease: Long-Term Efficacy and Safety

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Long-Term Outcome in Patients After Treatment for Cushing’s Disease in Childhood

PLoS ONE
Multidisciplinary
2019English

Long-Term Efficacy and Safety of Cardioneuroablation in Patients With Vagally Mediated Bradyarrhythmias

e-Journal of Cardiovascular Medicine
2020English

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

The Medical Treatment With Pasireotide in Cushing’s Disease: An Italian Multicentre Experience Based on “Real-World Evidence”

Endocrine
2019English

Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy

British Journal of Haematology
Hematology
2017English

Long-Term Safety and Efficacy of Olanzapine Long-Acting Injection in Patients With Schizophrenia or Schizoaffective Disorder

International Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2014English

Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Enlarged Adrenal Glands: The Long-Term Consequence of Cushing’s Disease

Endocrine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy